Crossref
Recent Advances and Clinical Value of Anlotinib Combined with Immunotherapy in Non-Small Cell Lung Cancer
Advances in Clinical Medicine · 2026 · 16 (04) · 4521-4531
DOI: 10.12677/acm.2026.1641723 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical Medicine, 2026. Verfasst von 雅辰 高. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
高, 雅. (2026). Recent Advances and Clinical Value of Anlotinib Combined with Immunotherapy in Non-Small Cell Lung Cancer. Advances in Clinical Medicine, 16(04), 4521-4531. https://doi.org/10.12677/acm.2026.1641723
Vancouver
高 雅. Recent Advances and Clinical Value of Anlotinib Combined with Immunotherapy in Non-Small Cell Lung Cancer. Advances in Clinical Medicine. 2026;16(04):4521-4531. doi:10.12677/acm.2026.1641723
BibTeX
@article{2026,
author = {高, 雅辰},
title = {Recent Advances and Clinical Value of Anlotinib Combined with Immunotherapy in Non-Small Cell Lung Cancer},
journal = {Advances in Clinical Medicine},
year = {2026},
volume = {16},
number = {04},
pages = {4521--4531},
doi = {10.12677/acm.2026.1641723}
}
EUVIMED